Your browser doesn't support javascript.
loading
[PSA kinetics after radiotherapy]. / Cinétique de PSA après radiothérapie.
Riedinger, J-M; Eche, N; Bachaud, J-M; Crehange, G; Fulla, Y; Thuillier, F.
Afiliação
  • Riedinger JM; Département de biologie et de pathologie des tumeurs, Laboratoire de biologie clinique, Centre Georges François Leclerc, Dijon. j.riedinger@dijon.fnclcc.fr
Ann Biol Clin (Paris) ; 67(4): 395-404, 2009.
Article em Fr | MEDLINE | ID: mdl-19656762
ABSTRACT
The prostate specific antigen (PSA) is the best marker of the prostate cancer today although not very specific of this pathology. The dynamic interpretation of this marker always has to prevail over that of overtaking a threshold. After radiotherapy, PSA can decrease after a mean interval of one to two years to a value less than 1 microg/L (predictive of recurrence-free survival). Biochemical recurrence after radiotherapy is defined by an increase of PSA by 2 microg/L or more above the PSA nadir, whether or not it is associated with endocrine therapy. The time of appearance of the recurrence and the PSA doubling time after total radiotherapy have a diagnostic value on the nature of the site of recurrence, local or metastatic.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Radioterapia / Antígeno Prostático Específico Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: Fr Revista: Ann Biol Clin (Paris) Ano de publicação: 2009 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Radioterapia / Antígeno Prostático Específico Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: Fr Revista: Ann Biol Clin (Paris) Ano de publicação: 2009 Tipo de documento: Article